The biosynthesis of fibronectin during the in vivo development of matrix-induced endochondral bone was investigated by using [3(5Smethionine in rats. The demineralized bone matrix that was implanted subcutaneously to induce local bone formation bound circulating fibronectin. This may be an important initial requirement for cell attachment to the matrix. Fibronectin was present throughout the development of bone but accounted for the largest percentage of total protein synthesized during mesenchymalcell proliferation and hematopoiesis. Fibronectin was identified in tissue extracts by its (i) comigration on electrophoretic NaDodSO4/polyacrylamide gels with human and rat plasma fibronectin, (ii) affinity for denatured collagen, (iii) It has been well documented (1, 2) that anchorage to a substratum is a fundamental condition for in vitro growth of normal fibroblasts. After the initial contact, cellular extensions attach to the surrounding surface (3) before the cells proliferate. It has been shown for many cell types that, without the addition of serum to the culture medium, cell attachment does not occur and subsequent growth does not ensue (4, 5). Fibronectin is a cell surface glycoprotein that is also present in serum and has been shown to function in vitro as an adhesive component for cell-substratum (usually collagen) or cell-cell interaction (for a review see ref. 6). The relevance of these observations to the in vivo situation has not been established. Extrapolating from the in vitro data to the in vivo situation, similar conditions for growth and differentiation may be required-i.e., anchorage of cells to a suitable substratum prior to cell proliferation. The aim of this study was to investigate changes in tissue fibronectin during mesenchymal cell proliferation and differentiation of cartilage and bone elicited in response to implanted collagenous matrix.
It has been well documented (1, 2) that anchorage to a substratum is a fundamental condition for in vitro growth of normal fibroblasts. After the initial contact, cellular extensions attach to the surrounding surface (3) before the cells proliferate. It has been shown for many cell types that, without the addition of serum to the culture medium, cell attachment does not occur and subsequent growth does not ensue (4, 5) . Fibronectin is a cell surface glycoprotein that is also present in serum and has been shown to function in vitro as an adhesive component for cell-substratum (usually collagen) or cell-cell interaction (for a review see ref. 6 ). The relevance of these observations to the in vivo situation has not been established. Extrapolating from the in vitro data to the in vivo situation, similar conditions for growth and differentiation may be required-i.e., anchorage of cells to a suitable substratum prior to cell proliferation. The aim of this study was to investigate changes in tissue fibronectin during mesenchymal cell proliferation and differentiation of cartilage and bone elicited in response to implanted collagenous matrix.
In order to study changes in tissue fibronectin during growth and development, we investigated matrix-induced endochondral bone formation in rats (7) (8) (9) (10) . After subcutaneous implantation of demineralized collagenous bone matrix, an invariant sequence of events ensues culminating in de novo cartilage, bone, and red marrow formation. In brief, 1 day after implantation of matrix, a transient inflammatory reaction is observed. Three days later mesenchymal cell proliferation occurs with the subsequent differentiation into chondroblasts on day 5. On day 7, a typical metachromatic matrix is evident. This is followed on day § 8-9 by vascularization, chondrolysis, and calcification of cartilage. Concurrently, mesenchymal precursor cells proliferate and differentiate into osteoblasts on day 10. Starting on day 11, bone develops and concomitant remodeling occurs on days 12-18 with the formation of hematopoietic bone marrow by day 21. Each of the above events can be characterized histologically and quantitated with specific biochemical markers (7) (8) (9) (10) . The present paper describes the biosynthesis and localization of fibronectin at the different developmental stages of collagenous matrix-induced endochondral bone formation.
MATERIALS AND METHODS
Preparation of Matrix and Implantation. Demineralized bone matrix prepared from rat diaphyses was implanted subcutaneously into 28-to 31-day-old (120-140 g) Long-Evans rats. The day of implantation was designated as day 0, with all surgical procedures and autopsies performed between 10 and 11 a.m. The present study investigated protein biosynthesis of various stages of matrix-induced bone formation that have been previously defined histologically and biochemically (7) (8) (9) (10) of the radioactivity was extracted in the presence of 4.0 M guanidine-HCI in Tris-HCI, pH 7.4. The remaining 5-10% radioactivity was extracted in 4.0 M guanidine-HCI, (pH 11.0). Based on the above information, a simplified extraction procedure was initiated by using Tris.HCI/PO4 buffer (pH 7.4) followed by 4 .0 M guanidine/50 mM Tris-HCl, pH 7.4, and 4.0 M guanidine/50 mM Na2CO3, pH 11.0, all with 0.25% Triton X-100 and the protease inhibitor solution described above. The trends of extractability as described above were also seen.
Determination of Radioactive Components Binding to Gelatin in Plaque Extracts. Gelatin-Sepharose affinity chromatography was performed on extracts from the developing plaques at different stages. The columns were prepared according to the procedure of Engvall and Ruoslahti (12) except for the use of salt-soluble lathrytic rat skin collagen (13) coupled to CNBr-activated Sepharose 4B at 56°C for 3 hr. An aliquot of the extract containing 200,000 cpm was applied to 5 ml of plain Sepharose 4B to remove any entity binding to the Sepharose 4B alone. It was determined that less than 5% of the total counts bound to the plain Sepharose 4B. The equilibrating and eluting buffer was 20 mM Na2HPO4/0.15 M NaCl/0.5 mM phenylmethylsulfon'yl fluoride at pH 7.4. The eluate from the plain Sepharose 4B was then passed over a 2-ml bed volume of the gelatin-Sepharose. The columns were eluted with 10 Fig. 1 . A band at about Mr 220,000 is present on all days. This band was collagenase insensitive (data not shown), comigrated with human and rat plasma fibronectin, and stained with purified antibody to rat plasma fibronectin. Therefore, this 220,000 Mr band was designated as fibronectin. Fluorographs of the gels indicated fibronectin was present on all days except day 1.
The 4.0 M guanidine buffer (pH 7.4) extract (after the Tris.HCI/PO4 extraction) of a day 3 plaque is shown in Fig. 2A .
The fibronectin band appears as a doublet at 220,000 on day 3 and is collagenase insensitive (Fig. 2A, lane 3) . The purified collagenase preparation was shown to degrade purified type I collagen under the same conditions. A similar doublet pattern was seen on days 7 and 12 as well. A fluorograph of 4.0 M guanidine buffer (pH 7.4) extracts of plaques is shown in Fig.  3 . It is noteworthy that there are labeled bands at high molecular weights (greater than 220,000), which may represent complexes of fibronectin with collagen extractable only in 4.0 M guanidine or incompletely reduced dimers and multimers of fibronectin.
The gel stained for protein revealed fibronectin on day 1 (Fig.  1, day 1) Determination of Gelatin-Binding Activity. Because fibronectin binds well to denatured collagen and gelatin-affinity columns are useful in its purification, we determined the amount of fibronectin present in the various extracts by measuring the percentage of total radioactivity bound to gelatinSepharose. Plaques were incubated for 3 hr in tissue culture medium with L-[a5SSmethionine prior to extraction in TrisHCl/P04 buffer. The percentage of total radioactivity washed off the column with 1.0 M urea for plaques from day 1 through day 21 ranged from 50 to 59%. A significant amount of radioactivity was eluted with 4.0 M urea. Days 3 and 21 had greater activities compared to days 1, 7, 9, 11 and 14, whereas day 1 had the least (Fig. 4) . Another the electrophoresed 4.0 and 8.0 M urea eluents from day 7 plaques showed that the 4.0 M eluent was primarily fibronectin, whereas the 8.0 M urea extract was primarily a 70,000 Mr protein (Fig. 2C) . There clearly are other lower molecular weight proteins in addition to fibronectin evident in the 4.0 M urea wash. Therefore, there may be more than one gelatinbinding protein in these tissue extracts. Alternatively, the lower molecular weight protein may represent breakdown products of fibronectin, even in the presence of the protease inhibitor phenylmethylsulfonyl fluoride.
Immunofluorescent Localization of Fibronectin. Indirect immunofluorescent localization of fibronectin in frozen sections of developing plaques by use of affinity purified antibody against rat fibronectin is shown in Fig. 5 . Negligible autofluorescence was detected when preimmune rabbit serum was used. On day 3 (Fig. 5A ) the extracellular matrix was reactive for fibronectin, especially in the area adjacent to the implanted matrix. On day 7 (Fig. 5B) in the differentiating cartilage, fibronectin was not detectable in the extracellular cartilage matrix whereas the chondrocytes were positive for fibronectin. Pretreatment of the sections with hyaluronidase revealed a moderate reaction in the matrix (unpublished results). In day 7 plaques, the area of undifferentiated mesenchymal tissue was also positive for fibronectin. During vascular invasion and prior to osteogenesis, fibronectin was localized in association with invading endothelial cells.
DISCUSSION
The biosynthesis of fibronectin has been demonstrated during the in ivo development of matrix-induced endochondral bone. Although fibronectin was present in the plaque throughout its development, an increase in fibronectin synthesis was greatest on day 3 after implantation when mesenchymal precursor cells (destined to be chondrocytes) proliferated and on day 21 during hematopoiesis. Fibronectin was identified by its (i) comigration on electrophoretic NaDodSO4 gels with human and rat plasma fibronectin, (ii) affinity for denatured collagen, (iii) insensitivity to collagenase digestion, and (iv) crossreactivity with purified antibody to rat fibronectin. Fibronectin extracted from de- (24) showed fibronectin to be absent from differentiated cartilage matrix. Yamada and Olden (6) and Pennypacker et al. (25) suggested that losses of fibronectin may be a prerequisite for differentiation of certain cells. These observations by earlier workers were on in vitro systems and on cartilage that does not subsequently differentiate into bone, in contrast to the endochondral bone formation studies here.
Our data suggest that differentiating chondrocytes may have fibronectin associated with them. Preliminary observations based on hyaluronidase pretreatment indicate that proteoglycans appeared to mask the localization of fibronectin in the cartilage matrix. The appearance of a significant amount of fibronectin in day 21 plaques can be correlated with the onset of hematopoiesis and the presence of endothelial elements in the sinusoids (8, 26 
